Analysis and a long-term follow up of ketosis-onset Japanese NIDDM patients

Diabetes Research and Clinical Practice

Volumn 44, Issue 2, 1999, Pages 137-146

  Tanaka, Keiji ^a   Moriya, Tatsumi ^a   Kanamori, Akira ^a   Yajima, Yoshitada ^a  

^a Kitasato University   (Japan)

Author keywords

Acute onset NIDDM patients; Diabetic ketoacidosis; Ketosis; Sugar containing soft drinks

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; C PEPTIDE; GLIBENCLAMIDE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BEVERAGE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DIET; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; HOSPITAL ADMISSION; HUMAN; INSULIN RELEASE; KETOACIDOSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; RECEPTOR GENE; SUGAR INTAKE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; DIABETIC KETOACIDOSIS; DIETARY SUCROSE; FEMALE; FOLLOW-UP STUDIES; HLA ANTIGENS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; JAPAN; MALE; MIDDLE AGED; OBESITY; TIME FACTORS;

EID: 0032878701     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00023-6     Document Type: Article

References (30)

1. Faich G.A., Fishbein H.A., Ellis S.E. The epidemiology of diabetic acidosis: a population-based study. Am. J. Epidemiol. 117:1983;551-558.
2. Cefalu W.T. Diabetic ketoacidosis. Crit. Care Clin. 7:1991;89-108.
3. Yamada K., Nonaka K. Diabetic ketoacidosis in young obese Japanese man. Diabetes Care. 19:1996;671.
4. Yamada K., Takane N., Nonaka K., Nakamura Y., Nunoi K. Obese NIDDM developing ketosis associated with soft drink consumption. J. Jpn. Diabetes Soc. 36:1993;469-473.
5. Nonaka K., Yamada K., Hayashi H. Soft-drink ketosis: a disease entity characteristically seen in obese young men in Japan. Kaneko T., Huh K.B., Shichiri M., Oka Y. Diabetes Mellitus: New Aspects of Pathogenesis and Treatment. 1997;115-116 Nishimura/Smith Gordon, UK.
6. Storlien L.H., Kraegen E.W., Jenkins A.B., Chisholm D.J. Effects of sucrose vs. starch diets on in vivo insulin action, thermogenesis, and obesity in rats. Am. J. Clin. Nutr. 47:1988;420-427.
7. Thorburn A.W., Storlien L.H., Jenkins A.B., Khouri S., Kraegen E.W. Fructose-induced in vivoinsulin resistance and elevated plasma triglyceride levels in rats. Am. J. Clin. Nutr. 49:1989;1155-1163.
8. Wright D.W., Hansen R.I., Mondon C.E., Reaven G.M. Sucrose-induced insulin resistance in the rat: modulation by exercise and diet. Am. J. Clin. Nutr. 38:1983;879-883.
9. Yoon J.W., Ihm S.H., Kim K.W. Viruses as a triggering factor of type 1 diabetes and genetic markers related to the susceptibility to the virus-associated diabetes. Diabetes Res. Clin. Pract. 7:1987;47-58.
10. World Health Organisation, Diabetes Mellitus, report of a WHO study group, Technical Report Series 727, World Health Organization, Geneva, 1985, pp. 111-113.
11. Kobayashi T., Itoh T., Kosaka K., Sato K., Tsuji K. Time course of islet antibodies and β-cell function in non-insulin-dependent stage of type I diabetes. Diabetes. 36:1987;510-517.
12. Yamaguchi A., Ogata K., Kubo H. et al. Performance and characteristic study of 'RIP Anti-GAD Hoechst' RIA kit in detection of anti-GAD antibodies. Med. Pharm. 31:1994;419-431.
13. Widen E., Lehto M., Kanninen T., Walston J., Shuldiner A.R., Groop L.C. Association of a polymorphism in the β-3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 333:1995;348-351.
14. Sakurami T., Ueno Y., Iwaki Y., Park M.S., Terasaki P.I., Saji H. HLA-DR specificities among Japanese with several autoimmune diseases. Tissue Antigen. 19:1982;129-133.
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 20:1997;1183-1197.
16. Kotani K., Tokunaga K., Fujioka S. et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int. J. Obes. Rel. Metab. Disord. 18:1994;202-207.
17. Yamashita S., Nakamura T., Shimomura I. et al. Insulin resistance and body fat distribution. Diabetes Care. 19:1996;287-291.
18. Kosaka K., Hagura R., Odagiri R., Saito F., Kuzuya T. Effect of weight changes on serum insulin response in subjects with normal oral glucose tolerance. J. Clin. Endocrinol. Metab. 35:1972;655-658.
19. Aizawa T., Katakura M., Taguchi N. Ketoacidosis-onset noninsulin dependent diabetes in Japanese subjects. Am. J. Med. Sci. 310:1995;198-201.
20. Kida K., Mimura G., Kobayashi T. et al. ICA and organ-specific autoantibodies among Japanese patients with early-onset insulin-dependent diabetes mellitus the JDS study. Diabetes Res. Clin. Pract. 23:1994;187-193.
21. Akamine H., Komiya I., Shimabukuro T. et al. High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65. Diabetic Med. 14:1997;778-784.
22. Kosaka K., Kuzuya T., Akanuma Y., Hagura R. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia. 18:1980;23-28.
23. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 15:1992;318-368.
24. Baron A.D., Zhu J.S., Zhu J.H. et al. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle: implications for glucose toxicity. J. Clin. Invest. 96:1995;2792-2801.
25. Leahy J.L. Detrimental effect of chronic hyperglycemia on the pancreatic β-cell. LeRoith D., Simeon S.I., Olefsky J.M. Diabetes Mellitus. 1996;103-113 Lippincott-Raven Publishers, PA.
26. Lonnqvist F., Thome A., Nilsell K., Hoffstedt J., Arner P. A pathogenic role of visceral fat β-3-adrenoceptors in obesity. J. Clin. Invest. 95:1995;1109-1116.
27. Enocksson S., Shimizu M., Lonnqvist F., Nordenstrom J., Arner P. Demonstration of an in vivo functional β-3-adrenoceptor in man. J. Clin. Invest. 95:1995;2239-2245.
28. Kadowaki H., Yasuda K., Iwamoto K. A mutation in the β-3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem. Biophys. Res. Commun. 215:1995;555-560.
29. Yoshida T., Sakane N., Umekawa T., Sakai M., Takahashi T., Kondo M. Mutation of β-3-adrenergic-receptor gene and response to treatment of obesity. Lancet. 346:1995;1433-1434.
30. Allison D.B., Heo M., Faith M.S., Pietrobelli A. Meta-analysis of the association of the Trp64Arg polymorphism in the β-3-adrenergic-receptor with body mass index. Intern. J. Obes. 22:1998;559-566.